ClinConnect ClinConnect Logo
Search / Trial NCT04952714

RRT With a Cytokine Absorption Filter (oXiris ®) in Patients With Septic Shock

Launched by CLINICA CES · Jul 2, 2021

Trial Information

Current as of May 11, 2025

Completed

Keywords

Renal Replacement Therapy

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients who enter the Intensive Care Unit of the CES Clinic during the recruitment period with:
  • Diagnosis of septic shock of any origin according to the definition of the Sepsis-3 consensus.
  • Acute renal injury according to the KDIGO 2012 classification that requires continuous renal replacement therapy and that its origin is presumed to be septic origin.
  • In invasive ventilatory support.
  • Informed consent previously filled out by a guardian.
  • Exclusion Criteria:
  • Patients under 18 years of age and women in pregnancy or postpartum will be excluded.
  • Chronic kidney disease that requires RRT on an outpatient basis before admission to the ICU.
  • Contraindication to the use of heparins or another anticoagulant
  • Dissent to escalate therapeutic measures
  • Terminal or irrecoverable condition according to the criteria of the specialist in critical medicine and intensive care

About Clinica Ces

Clinica CES is a leading clinical research organization dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. With a commitment to ethical practices and patient safety, Clinica CES collaborates with healthcare professionals, researchers, and sponsors to design and implement studies across various therapeutic areas. Their expertise in trial management, regulatory compliance, and data analysis ensures the efficient execution of high-quality research, contributing to the development of new therapies and treatments. By fostering a culture of collaboration and excellence, Clinica CES plays a pivotal role in the advancement of medical science.

Locations

Medellín, Antioquia, Colombia

Patients applied

0 patients applied

Trial Officials

David Yepes-Gómez, MD, MSc

Principal Investigator

Clinica CES

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials